Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Apr;23(4):589–592. doi: 10.1128/aac.23.4.589

Effects of cloned interferon alpha 2 in normal volunteers: febrile reactions and changes in circulating corticosteroids and trace metals.

G M Scott, R J Ward, D J Wright, J A Robinson, J K Onwubalili, C L Gauci
PMCID: PMC184706  PMID: 6859837

Abstract

Six healthy volunteers were given single intramuscular injections of an ascending dose schedule of human interferon alpha 2 (Hu IFN alpha 2) from Escherichia coli. At a dose of 3 X 10(6) U, all of the volunteers had febrile reactions with influenza-like symptoms as previously described for purified natural leukocyte interferon. Significant rises in serum 11-hydroxycorticosteroids and falls in plasma zinc levels were observed at this highest dose. Although there was a reduction in the febrile reaction complex, the simultaneous administration of indomethacin with a "toxic" dose of interferon did not alter the changes in white cells, corticosteroids, or trace metals. Nonspecific effects must be considered in the therapeutic activity of interferon.

Full text

PDF
589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blalock J. E., Smith E. M. Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5972–5974. doi: 10.1073/pnas.77.10.5972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DE MAEYER E., DE MAEYER J. Two-sided effect of steroids on interferon in tissue culture. Nature. 1963 Feb 16;197:724–725. doi: 10.1038/197724a0. [DOI] [PubMed] [Google Scholar]
  3. Fumarola D. Toxicity of interferon. Br Med J (Clin Res Ed) 1981 Jul 18;283(6285):235–235. doi: 10.1136/bmj.283.6285.235-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gutterman J. U., Fine S., Quesada J., Horning S. J., Levine J. F., Alexanian R., Bernhardt L., Kramer M., Spiegel H., Colburn W. Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. Ann Intern Med. 1982 May;96(5):549–556. doi: 10.7326/0003-4819-96-5-549. [DOI] [PubMed] [Google Scholar]
  5. KILBOURNE E. D., SMART K. M., POKORNY B. A. Inhibition by cortisone of the synthesis and action of interferon. Nature. 1961 May 13;190:650–651. doi: 10.1038/190650a0. [DOI] [PubMed] [Google Scholar]
  6. Scott G. M., Secher D. S., Flowers D., Bate J., Cantell K., Tyrrell D. A. Toxicity of interferon. Br Med J (Clin Res Ed) 1981 Apr 25;282(6273):1345–1348. doi: 10.1136/bmj.282.6273.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Secher D. S. Immunoradiometric assay of human leukocyte interferon using monoclonal antibody. Nature. 1981 Apr 9;290(5806):501–503. doi: 10.1038/290501a0. [DOI] [PubMed] [Google Scholar]
  8. Taylor A., Bryant T. N. Comparison of procedures for determination of copper and zinc in serum by atomic absorption spectroscopy. Clin Chim Acta. 1981 Feb 19;110(1):83–90. doi: 10.1016/0009-8981(81)90304-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES